Hepatitis C Prevalence and Injection Drug Use in Greece

"According to DRID data, HCV antibody prevalence in IDUs has been consistently high and increasing over the last 10 years in Greece. In 2011, prevalence rates ranged between 62.4% and 79.3%, depending on the source of data (Figure 6.4). Compared to 2010, in 2011 HCV infection rates remained stable in data source 1 (national sample), but increased significantly in data sources 2 (national sample) and 3 (Athens sample) (Figure 6.4)."